Hypertension does not account for the accelerated atherosclerosis and development of aneurysms in male apolipoprotein E/endothelial nitric oxide synthase double knockout mice

被引:133
作者
Chen, JQ
Kuhlencordt, PJ
Astern, J
Gyurko, R
Huang, PL
机构
[1] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA
[3] Harvard Univ, Sch Med, Boston, MA 02115 USA
关键词
arteriosclerosis; nitric oxide synthase; aneurysm; hypertension; hydralazine;
D O I
10.1161/hc4501.099729
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Apolipoprotein E (apoE)/endothelial nitric oxide synthase (eNOS) double knockout (DKO) mice demonstrate accelerated atherosclerosis and develop abdominal aortic aneurysms and aortic dissection, suggesting a role for eNOS in suppressing atherogenesis. To test whether accelerated atherosclerosis and aortic aneurysms were due to hypertension, we administered hydralazine to male apoE/eNOS DKO mice to reduce blood pressure. Methods and Results-Male apoE/eNOS DKO mice were treated with hydralazine in their drinking water (250 mg/L) using a dose that lowers the blood pressure to levels seen in apoE KO mice. The mice were fed a Western-type diet for 16 weeks, and lesion formation was assessed by inspection of the vessel and staining with Sudan IV. Hydralazine-treated, normotensive male apoE/eNOS DKO mice developed increased aortic lesion areas (30.0 +/-2.8%, n=11) compared with male apoE KO mice (14.6 +/-0.8%, n=7). The extent of lesion formation was not significantly different from male apoE/eNOS DKO mice that were not given hydralazine (28.3 +/-3.1%, n=9). Four of 11 hydralazine-treated male apoE/eNOS DKO mice developed abdominal aortic aneurysms. Conclusions-Hypertension is not required for the accelerated atherosclerosis seen in apoE/eNOS DKO animals, and control of hypertension during a 16-week period does not prevent aortic aneurysm formation.
引用
收藏
页码:2391 / 2394
页数:4
相关论文
共 15 条
[1]   Modulation of mouse cardiac function in vivo by eNOS and ANP [J].
Gyurko, R ;
Kuhlencordt, P ;
Fishman, MC ;
Huang, PL .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2000, 278 (03) :H971-H981
[2]   The angiotensin-converting enzyme inhibitor, fosinopril, and the angiotensin II receptor antagonist, losartan, inhibit LDL oxidation and attenuate atherosclerosis independent of lowering blood pressure in apolipoprotein E deficient mice [J].
Hayek, T ;
Attias, J ;
Coleman, R ;
Brodsky, S ;
Smith, J ;
Breslow, JL ;
Keidar, S .
CARDIOVASCULAR RESEARCH, 1999, 44 (03) :579-587
[3]   HYPERTENSION IN MICE LACKING THE GENE FOR ENDOTHELIAL NITRIC-OXIDE SYNTHASE [J].
HUANG, PL ;
HUANG, ZH ;
MASHIMO, H ;
BLOCH, KD ;
MOSKOWITZ, MA ;
BEVAN, JA ;
FISHMAN, MC .
NATURE, 1995, 377 (6546) :239-242
[4]   Lisinopril reduces left ventricular hypertrophy and cardiac polyamine concentrations without a reduction in left ventricular wan stress in transgenic Tsukuba hypertensive mice [J].
Kai, T ;
Ishikawa, K .
HYPERTENSION RESEARCH, 2000, 23 (06) :625-631
[5]   Role of endogenous nitric oxide in progression of atherosclerosis in apolipoprotein E-deficient mice [J].
Kauser, K ;
Da Cunha, V ;
Fitch, R ;
Mallari, C ;
Rubanyi, GM .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2000, 278 (05) :H1679-H1685
[6]   Enhanced atherosclerosis and kidney dysfunction in eNOS-/-Apo-/- mice are ameliorated by enalapril treatment [J].
Knowles, JW ;
Reddick, RL ;
Jennette, JC ;
Shesely, EG ;
Smithies, O ;
Maeda, N .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (04) :451-458
[7]   Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice [J].
Kuhlencordt, PJ ;
Gyurko, R ;
Han, F ;
Scherrer-Crosbie, M ;
Aretz, TH ;
Hajjar, R ;
Picard, MH ;
Huang, PL .
CIRCULATION, 2001, 104 (04) :448-454
[8]  
LEFER AM, 1993, AGENT ACTION SUPPL, V41, P127
[9]   NITRIC-OXIDE (NO) DONOR MOLECULES - EFFECT OF NO RELEASE RATE ON VASCULAR SMOOTH-MUSCLE CELL-PROLIFERATION IN-VITRO [J].
MOORADIAN, DL ;
HUTSELL, TC ;
KEEFER, LK .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1995, 25 (04) :674-678
[10]   APOE-DEFICIENT MICE DEVELOP LESIONS OF ALL PHASES OF ATHEROSCLEROSIS THROUGHOUT THE ARTERIAL TREE [J].
NAKASHIMA, Y ;
PLUMP, AS ;
RAINES, EW ;
BRESLOW, JL ;
ROSS, R .
ARTERIOSCLEROSIS AND THROMBOSIS, 1994, 14 (01) :133-140